$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Mitochondria exist in every cell in the body except red blood cells and are involved in a large number of important cellular and metabolic processes1-4. Because of these many functions, mitochondrial damage can have detrimental effects3. In order to investigate mitochondrial function and dysfunction several mitochondrial isolation methods have been described. The earliest published accounts of mitochondrial isolation date to the 1940s5-8. The first documented attempt demonstrated mitochondrial isolation by grinding liver tissue in a mortar followed by centrifugation in a salt solution at low speed5,8. Later, other groups expanded upon the original procedure and demonstrated tissue fractionation based on differential centrifugation6-8. These early methods formed the basis of current techniques which often incorporate homogenization, and/or differential centrifugation9-15. The number of homogenization and centrifugation steps varies among protocols. These repetitive steps increase the time for mitochondrial isolation and ultimately reduce viability. In addition, manual homogenization can cause mitochondrial damage and inconsistent results if not properly controlled10,16.
Recently, we used homogenization and differential centrifugation to isolate mitochondria for transplantation into myocardial tissue17,18. This lengthy isolation procedure required approximately 90 min and the clinical applicability of this method was therefore limited. To allow for acute therapeutic use in clinical and surgical treatment we have developed a rapid mitochondrial isolation procedure that can be performed in less than 30 min.
The major benefits of this protocol are that standardized tissue dissociation allows for uniform and consistent homogenization of tissue that is not easily achieved with manual homogenization. In addition, the use of differential filtration in place of differential centrifugation eliminates time consuming and repetitive centrifugation steps allowing for more rapid isolation of highly purified, viable and respiration competent mitochondria.
The ability to isolate viable and respiration competent mitochondria in less than 30 min allows for clinical applicability. This isolation protocol has potential for use in coronary artery bypass grafting surgery (CABG) and other therapeutic procedures.